The document is an intimation of an Analyst/Investor Meet scheduled as a conference call for analysts and institutional investors.
The event will be held on Friday, July 17, 2026, at 4:00 PM IST to discuss the Audited Financial Results (Standalone and Consolidated) for the quarter and year ended March 31, 2026 (FY26).
The stated purpose is to discuss the operational and financial performance for FY26, and it is specifically noted as the company's maiden earnings conference call.
The meeting is scheduled after the earnings announcement, as it will discuss the already announced audited financial results.
Management participants include: Mr. Vikram Kelkar (Managing Director), Dr. Nikhil Kelkar (Jt Managing Director), and Mr. Soman Jana (Chief Financial Officer).
The company has explicitly stated that no Unpublished Price Sensitive Information (UPSI) will be shared during the meeting.
The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically under Para A (15)(a) of Part A of Schedule III.
Additional Notes Section
The document includes an enclosure with details for the conference call, including dial-in numbers and a Diamond Pass registration link.
No financial data, results, or guidance figures were disclosed in this announcement. The call is scheduled to discuss results that have presumably been announced separately.
The disclosure is also available on the company's website at www.hexagonnutrition.com.
